Institutional investors purchased a net $225.3 thousand shares of MNOV during the quarter ended June 2017, and now own 19.16% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 34.5 Thousand shares of MediciNova Inc
CREATIVE PLANNING, INC. Sold 8.0 Thousand shares of MediciNova Inc